Ahmed Aribi, N. H. Thoennissen, Gabriela B. Iwanski, Dhong Hyun Tony Lee, Kunik Lee, Ngan B. Doan, Kin Tak Chan, Melvin Toh, Jonathan W. Said and H. Phillip. Koeffler, The triterpenoid Cucurbitacin B augments the anti-proliferative activity of chemotherapy in human breast cancer. Submitted to clinical cancer research.
Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian H. Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms. J Clin Oncol. 2009 Nov 10;27(32):5425-30. Epub 2009 Oct 5
Aribi A, Kantarjian H, Koller C, Thomas D, Faderl S, Garcia-Manero G, Cortes J. The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia. Cancer. 2008 Sep 15;113(6):1338-43.
Aribi A, Bueso-Ramos C, Estey E, Estrov Z, O'brien S, Giles F, Faderl S, Thomas D,
Kebriaei P, Garcia-Manero G, Pierce S, Cortes J, Kantarjian H, Ravandi F. Biphenotypic acute leukaemia: a case series. Br J Haematol. 2007 Jul;138(2):213-6.
Aribi A, Kantarjian HM, Estey EH, Koller CA, Thomas DA, Kornblau SM, Faderl SH, Laddie NM, Garcia-Manero G, Cortes JE. Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia. Cancer. 2007 Apr 1;109(7):1355-9.
Aribi A, Borthakur G, Ravandi F, Shan J, Davisson J, Cortes J, Kantarjian H. Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia. Cancer. 2007 Feb 15;109(4):713-7.
Kantarjian HM, O'Brien S, Shan J, Aribi A, Garcia-Manero G, Jabbour E, Ravandi F, Cortes J, Davisson J, Issa JP. Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome. Cancer. 2007 Jan 15;109(2):265-73.
Aribi A, Huh Y, Keating M, O'brien S, Ferrajoli A, Faderl S, Wierda W, Kantarjian H, Ravandi F. T-cell large granular lymphocytic (T-LGL) leukemia: Experience in a single institution over 8 years. Leuk Res. Jul; 31(7):939-45. 2006 Oct 12.
Aribi A, F Ravandi, F Giles. Novel agents in acute myeloid leukemia. Cancer J. 2006 Mar-Apr; 12(2):77-91.
Quintas-Cardama A, Aribi A, Cortes J, Giles FJ, Kantarjian H, Verstovsek S. Novel approaches in the treatment of systemic mastocytosis. Cancer. 2006 Oct 1; 107(7):1429-39. Review.
JiMing Cheng, Ming Ding, Ahmed Aribi, Prabodh Shah, Krishna Rao. Loss of RAB25 expression in breast cancer. Int J Cancer. 2006 Jun 15; 118(12): 2957-64.
Stringer, J.L. Aribi, A.M Effects of glial toxins on extracellular acidification in the hippocampal CA1 region in vivo. Epilepsy Res. 2003 May; 54(2-3):163-70.
Stringer, J.L. Aribi, A.M Modulation of the in vivo effects of gabapentin by vigabatrin and SKF89976A. Epilepsy Res. 2002 Dec; 52(2):129-37.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 9/11
